(Q38009064)

26 August 2017

Vitamin D in the aetiology and management of polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

26 August 2017

0 references

1 reference

1 reference

Rebecca L Thomson

1

1 reference

PubMed ID

22574874

26 August 2017

Simon Spedding

series ordinal

2

1 reference

PubMed ID

22574874

26 August 2017

Jonathan D Buckley

series ordinal

3

1 reference

26 August 2017

1 September 2012

1 reference

26 August 2017

Clinical Endocrinology

1 reference

26 August 2017

77

1 reference

26 August 2017

3

1 reference

26 August 2017

343-350

1 reference

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

The impact of obesity on reproduction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Association between Hypoadiponectinemia and Low Serum Concentrations of Calcium and Vitamin D in Women with Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D and calcium dysregulation in the polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D deficiency: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Worldwide status of vitamin D nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D: emerging new roles in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D (soltriol), light, and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Replete vitamin D stores predict reproductive success following in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Putting cardiovascular disease and vitamin D insufficiency into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D and mortality in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Depression in women with polycystic ovary syndrome: clinical and biochemical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Polycystic ovary syndrome and mental health: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Quality of life and psychological well being in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

Vitamin D and mood disorders among women: an integrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04434.X

10.1111/J.1365-2265.2012.04434.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22574874